ClinicalTrials.Veeva

Menu

A New Combination of Evidence-Based Interventions to Improve Primary Care Diagnostic Safety and Efficiency

The University of Texas System (UT) logo

The University of Texas System (UT)

Status

Enrolling

Conditions

Anemia
Decreased Glomerular Filtration Rate

Treatments

Other: Enhanced diagnostic team implementing three evidence-based interventions
Other: Usual care

Study type

Interventional

Funder types

Other

Identifiers

NCT05735314
HSC-MS-22-0815

Details and patient eligibility

About

The purpose of this study is to measure the evidence-based intervention's (EBIs) impact on patient safety and efficiency, to assess the EBIs implementation by measuring acceptability, appropriateness, cost, fidelity, penetration, and sustainability and to identify the facilitators and barriers that influence the degree of implementation of these EBIs.

Enrollment

450 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion and exclusion criteria

Primary care providers' inclusion criteria:

  • physicians, physicians assistants and advanced practice registered nurses in the 13 clinic locations of UTP are eligible if they care for patients at the time patient enrollment at their clinic begins
  • agree to participate.

Patients' inclusion criteria are:

  • hemoglobin result < 10.8 for females and < 12.5 for males with normal white cell count and platelet count (the prior hemoglobin results must have been in normal range, with a look-back period of two years)
  • an eGFR value < 60 (the prior eGFR results must have been in normal range, with a look-back range of two years)
  • the matching creatinine results must also be in normal range
  • not pregnant
  • speak English or Spanish.

Trial design

Primary purpose

Health Services Research

Allocation

Randomized

Interventional model

Crossover Assignment

Masking

None (Open label)

450 participants in 4 patient groups

Experimental: Step 1 (3 clinics) - 24 months of intervention
Experimental group
Treatment:
Other: Usual care
Other: Enhanced diagnostic team implementing three evidence-based interventions
Experimental: Step 2 (3 clinics) - 1 month of control followed by 18 months of intervention
Experimental group
Treatment:
Other: Usual care
Other: Enhanced diagnostic team implementing three evidence-based interventions
Experimental: Step 3 (3 clinics) - 2 months control followed by 12 months of intervention
Experimental group
Treatment:
Other: Usual care
Other: Enhanced diagnostic team implementing three evidence-based interventions
Experimental: Step 4 (4 clinics) - 2 months control followed by 12 months of intervention
Experimental group
Treatment:
Other: Usual care
Other: Enhanced diagnostic team implementing three evidence-based interventions

Trial contacts and locations

1

Loading...

Central trial contact

Eric Thomas, MD, MPH; Eric Thomas, MD,MPH

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems